News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,368 Results
Type
Article (56)
Press Release (6312)
Section
Business (2604)
Career Advice (4)
Deals (383)
Drug Development (1318)
FDA (227)
Job Trends (411)
News (4256)
Policy (225)
Tag
Academia (7)
Allergies (4)
Alliances (86)
ALS (1)
Alzheimer's disease (41)
Approvals (247)
Artificial intelligence (2)
Bankruptcy (1)
Best Places to Work (463)
Bladder cancer (8)
Breast cancer (10)
Cancer (108)
Cardiovascular disease (3)
Career advice (3)
CAR-T (2)
Cell therapy (4)
Cervical cancer (3)
Clinical research (1299)
Collaboration (7)
Compensation (1)
COVID-19 (10)
CRISPR (2)
Data (125)
Diabetes (5)
Diagnostics (61)
Drug discovery (2)
Drug pricing (1)
Earnings (2712)
Events (645)
Executive appointments (1)
FDA (279)
Frontotemporal dementia (1)
Funding (6)
Gene editing (2)
Generative AI (1)
Gene therapy (9)
GLP-1 (9)
Government (25)
Guidances (5)
Healthcare (167)
Indications (1)
Infectious disease (16)
Inflammatory bowel disease (2)
Influenza (1)
IPO (323)
IRA (1)
Job creations (5)
Job search strategy (3)
Kidney cancer (2)
Layoffs (3)
Legal (10)
Liver cancer (1)
Lung cancer (31)
Lymphoma (10)
Manufacturing (2)
MASH (4)
Medical device (202)
Medtech (202)
Mergers & acquisitions (65)
Metabolic disorders (11)
Multiple sclerosis (2)
NASH (2)
Neuroscience (53)
NextGen: Class of 2025 (16)
Non-profit (20)
Northern California (72)
Obesity (3)
Opinion (1)
Pancreatic cancer (1)
Parkinson's disease (5)
Patient recruitment (1)
Peanut (4)
People (29)
Phase I (186)
Phase II (389)
Phase III (757)
Pipeline (76)
Policy (1)
Postmarket research (86)
Preclinical (29)
Prostate cancer (3)
Radiopharmaceuticals (7)
Rare diseases (6)
Real estate (2)
Regulatory (256)
Reports (2)
Research institute (10)
Resumes & cover letters (2)
Rett syndrome (1)
RSV (4)
Schizophrenia (2)
Series B (1)
Sickle cell disease (1)
Southern California (33)
Spinal muscular atrophy (1)
Startups (4)
United States (545)
Vaccines (12)
Date
Today (3)
Last 7 days (32)
Last 30 days (62)
Last 365 days (862)
2025 (292)
2024 (777)
2023 (760)
2022 (807)
2021 (873)
2020 (610)
2019 (414)
2018 (359)
2017 (269)
2016 (132)
2015 (188)
2014 (114)
2013 (69)
2012 (93)
2011 (99)
2010 (92)
Location
Africa (1)
Arizona (4)
Asia (479)
Australia (25)
California (120)
Canada (27)
China (13)
Colorado (2)
Connecticut (4)
Delaware (23)
Europe (1140)
Florida (21)
Georgia (4)
Illinois (9)
India (1)
Indiana (19)
Iowa (1)
Japan (11)
Kansas (5)
Maryland (21)
Massachusetts (81)
Michigan (5)
Minnesota (3)
Missouri (2)
Nevada (1)
New Jersey (96)
New York (46)
North Carolina (14)
Northern California (72)
Ohio (3)
Pennsylvania (30)
South America (6)
Southern California (33)
Tennessee (1)
Texas (18)
Utah (6)
Virginia (2)
Washington State (10)
Wisconsin (1)
6,368 Results for "%E2%80%9D".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
April 30, 2025
·
1 min read
Press Releases
ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
April 29, 2025
·
1 min read
Press Releases
Encora Therapeutics’ Abstract at 2025 American Academy of Neurology (AAN) Annual Meeting Selected for Merit as “Abstract of Distinction”
April 14, 2025
·
2 min read
Press Releases
U-Factor Announces “Excellence Award” for ALS Research by Partner Hitonowa Medical Clinic at the 24th Congress of the Japanese Society for Regenerative Medicine
April 24, 2025
·
2 min read
Press Releases
ICON Reports First Quarter 2025 Results
May 1, 2025
·
13 min read
Press Releases
80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
April 29, 2025
·
5 min read
Press Releases
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
March 31, 2025
·
7 min read
Press Releases
ABIONYX Pharma, winner of the France 2030 Plan’s “i-Démo” call for projects, awarded €8.7 million from the French government to fight against Sepsis, the 3rd leading cause of death worldwide
February 20, 2025
·
1 min read
Press Releases
Guerbet: Q1 2025 revenue
April 25, 2025
·
7 min read
Press Releases
Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
April 28, 2025
·
10 min read
1 of 637
Next
